cytokine induced killer cells
Cell therapyexperimental
In cell biology, a lymphokine-activated killer cell is a white blood cell, consisting mostly of natural killer, natural killer T, and T cells that has been stimulated to kill tumor cells, but because of the function in which they activate, and the cells they can successfully target, they are classified as different than the classical natural killer and T lymphocyte systems. — Wikipedia
Clinical trial activity
55 trials · 52 clinical orgs · 0 marketing orgs
Phase 1
27
Phase 2
41
Phase 3
7
Phase 4
2
Earliest trial started Jul 1, 1993 (NCT00002535)
Timeline
Indications
Approved for
Studied for
- Adenocarcinoma of Lung · Phase 2
- Anemia · Phase 2
- Bone Marrow Cells · Phase 1
- Bone Marrow Transplantation · Phase 2
- Brain Neoplasms · Phase 2
- Breast Neoplasms · Phase 1/Phase 2
- Carcinoma, Hepatocellular · Phase 3
- Carcinoma, Non-Small-Cell Lung · Phase 2/Phase 3
- Carcinoma, Renal Cell · Phase 1/Phase 2
- Carcinoma, Squamous Cell · Phase 2/Phase 3
- Cholangiocarcinoma · Phase 2/Phase 3
- Colonic Neoplasms · Phase 3
- Colorectal Neoplasms · Phase 4
- Cytokine-Induced Killer Cells · Phase 4
- Esophageal Neoplasms · Phase 1/Phase 2
- Esophageal Squamous Cell Carcinoma · Phase 2
- Glioma · Phase 4
- Hematologic Neoplasms · Phase 2
- Kidney Neoplasms · Phase 1/Phase 2
- Leukemia · Phase 1
- Leukemia, Myeloid · Phase 2
- Leukemia, Myeloid, Acute · Phase 1/Phase 2
- Liver Neoplasms · Phase 2
- Lung Neoplasms · Phase 1/Phase 2
- Lymphoma, B-Cell · Phase 1/Phase 2
- Lymphoma, Non-Hodgkin · Phase 2
- Melanoma · Phase 2
- Multiple Myeloma · Phase 1
- Myelodysplastic Syndromes · Phase 2
- Myeloproliferative Disorders · Phase 2
- Nasopharyngeal Carcinoma · Phase 1/Phase 2
- Neoplasms · Phase 2/Phase 3
- Neural Tube Defects · Phase 2
- Neuroblastoma · Phase 1/Phase 2
- Ovarian Neoplasms · Phase 2
- Pancreatic Neoplasms · Phase 2/Phase 3
- Postoperative Complications · Phase 4
- Sarcoma · Phase 1/Phase 2
- Small Cell Lung Carcinoma · Phase 1/Phase 2
- Stomach Neoplasms · Phase 2
- Survival · Phase 4
- Urinary Bladder Neoplasms · Phase 2
- Uterine Cervical Neoplasms · Phase 2
Mechanism of action
- cytokine-induced killer cellsImmunity, passive
cytokine-induced killer cells immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLymphokine-activated killer cell ↗
Also known as
- cytokine-induced killer cell
- cytokine induced killer cells
- cytokine-induced killer cells
- lymphokine-activated killer cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05676190 | N/A | Jan 9, 2023 | People's Liberation Army of China |
| NCT05955157 | Phase 2/Phase 3 (Phase 3) | Jan 3, 2023 | University of Malaya |
| NCT05108077 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2022 | Belarusian State Medical University, National Academy of Sciences of Belarus |
| NCT03282435 | Phase 1 | Jan 31, 2018 | Dalian Medical University |
| NCT03329664 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2018 | Government of Iran, Sabz Biomedicals, University of Tehran |
| NCT03124498 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2017 | Chuan An Biotechnology Co., Ltd. |
| NCT03146637 | Phase 2 | May 1, 2017 | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd., People's Liberation Army of China |
| NCT03047525 | Phase 1/Phase 2 (Phase 2) | Feb 20, 2017 | Harbin Medical University |
| NCT01631357 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2016 | Nanjing Medical University, Tianjin Medical University |
| NCT03002831 | Phase 2 | Nov 1, 2016 | Henan Medical University, Zhengzhou University |
| NCT03190811 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2016 | Capital Medical University, Duke University |
| NCT02886897 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2016 | Sun Yat-Sen University |
| NCT02752243 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2016 | J. W. Goethe University |
| NCT02489890 | Phase 2 | Feb 1, 2016 | The First People's Hospital of Changzhou |
| NCT02585908 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2015 | Beijing Doing Biomedical Co., Ltd. |
| NCT02621333 | Phase 2 | Oct 1, 2015 | Anyang Regional Hospital, First People's Hospital of Shangqiu, Hebei University, Henan Medical University, Jiaozuo Tumor Hospital, Nanyang Central Hospital, Nanyang Medical College, People's Liberation Army of China, Puyang Oil Field General Hospital, Shanxi Medical University, Shenma Medical Group General Hospital, Tangshan People's Hospital, Xinyang Central Hospital |
| NCT02490735 | Phase 2 | Aug 1, 2015 | The First People's Hospital of Changzhou |
| NCT02498756 | Phase 2 | Aug 1, 2015 | The First People's Hospital of Changzhou |
| NCT02494804 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2015 | The First People's Hospital of Changzhou |
| NCT02493582 | Phase 2 | Jul 1, 2015 | The First People's Hospital of Changzhou |
Showing 20 of 55 trials
Page 1 / 3
Organizations
Research & Development (52)
52 organizations
Page 1 / 3